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Social/Health Maintenance Organization and 
Fee-for-Service Health Outcomes OverTime 
Kenneth G. Manton, Ph.D., Robert Newcomer, Ph.D., Gene R. Lowrimore, Ph.D., James C. Vertrees, Ph.D., 
and Charlene Harrington, Ph.D. 
Evaluating the performance of long-
term care (LTC) demonstrations requires 
longitudinal assessment of multiple out-
comes where selective mortality and dis-
enrollment, if not accounted for, can give 
the appearance of reduced (or enhanced) 
efficacy. We assessed outcomes in social/ 
health maintenance organizations 
(S/HMOs) and Medicare fee-for-service 
(FFS) care using a multivariate model to 
estimate active life expectancy (ALE). 
S/HMO enrollees and samples of FFS cli-
ents in four sites were analyzed and out-
come differences assessed for a 3-year 
period. Results provide insights into 
S/HMO performance under different con-
ditions and, more generally, into evaluat-
ing LTC demonstrations without random-
ized client and control groups. 
INTRODUCTION 
The utility of LTC for functionally im-
paired, community dwelling elderly is well 
documented. In-home services (for meal 
preparation, shopping, laundry, groom-
ing, and dressing) and out-of-home serv-
ices (such as adult day care, recreational, 
physical, and occupational therapy) im-
prove client and caregiver lives (e.g., 
Kemper, 1988). The value of case manage-
ment (i.e., needs assessment, care plan-
ning, coordinating and monitoring of ser-
vices) is also evident. Though improving 
client and caregiver outcomes, however, 
these services do not appear to reduce 
costs—possibly due to methodological 
factors (e.g., defining their cost effective-
ness relative to institutional care) (Kemper, 
1988; Weissert, Cready, and Pawelak, 
1988; Zawadski, 1984). Institutional costs 
are limited by State Medicaid programs 
and may be insufficient to bring about 
therapeutic innovations or to prevent 
quality-of-care problems (e.g., decubitus 
ulcer, malnutrition, pneumonia, or urinary 
tract infection [UTI]) (Brandeis et al. 1990; 
Braun, 1991; Dontas et al., 1991; Fiatarone 
et al. 1990; Gloth et al., 1991; Gross, 1988; 
Pinchcofsky-Devin and Kaminski, 1987). 
Consequently, an alternative model for 
delivering LTC to community popula-
tions, the S/HMO, was developed. It was 
hoped that LTC, provided in a capitated 
system (as it is in a S/HMO), might im-
prove cost effectiveness and outcomes. 
A Health Care Financing Administration 
(HCFA) demonstration of S/HMOs started 
in January 1985. S/HMOs were to: 
• Provide hospital, physician, home 
health, extended benefit (e.g., eye 
glasses, hearing aids, drugs) and LTC 
services (e.g., nursing home, home-
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maker, and transport) to voluntarily en-
rolled clients paying a monthly pre-
mium. 
• Use case managers to determine eligi-
bility for, and select, LTC services. Ac-
cess is limited by disability criteria and 
coverage limits. 
• Serve both impaired and unimpaired el-
derly to maintain health and function. 
• Be reimbursed by capitation payments 
from pooled Medicare, Medicaid (for eli-
gible enrollees), and member premi-
ums. S/HMOs assumed risk for all 
costs after 30 months. Integrated fund-
ing and financial risk are incentives for 
cost control and service flexibility (Leutz 
et al.,1985). 
Some S/HMO features complicate the 
evaluation process. Because enrollment 
is voluntary, and marketability important, 
persons with specific health attributes 
can self-select into S/HMOs. Thus, a ran-
domized study design could not be used. 
Statistical controls for health differences 
between S/HMO enrollees and members 
of comparison FFS samples are neces-
sary. Additionally, the LTC provided by 
S/HMOs is available to persons in FFS. 
That is, the intervention depends on the 
degree to which S/HMOs make LTC ac-
cessible and not on its presence or ab-
sence. Variation in interventions makes 
comparisons of S/HMO and FFS out-
comes complex. Here we focus on one 
outcome—the effect of being in a S/HMO 
on a person's functioning, relative to be-
ing in Medicare FFS, controlling for initial 
health and mortality. In this analysis we 
do not deal with cost issues, as they are 
treated in other reports. 
Comparing outcomes longitudinally 
between S/HMO enrollees and FFS sam-
ples is difficult because of systematic 
health changes, mortality, and sample 
loss. For example, in the National Long-
Term Care Channeling demonstration, 
the effect of increased access to case 
management (both with and without pay-
ments for additional services) was evalu-
ated in 10 sites during an 18-month pe-
riod. Persons with impairments were 
selected for the study and randomized 
into one of four groups (i.e., case and con-
trol groups defined for two interventions). 
Differences were found on baseline inter-
views in case and control response rates 
(10 percent higher for cases), response 
times (cases responded 5.4 days faster), 
and willingness (cases, on average, re-
quired 29 percent fewer contacts). Timing 
was important in assessing hospitalized 
or institutionalized persons (Brown and 
Mossel, 1984). 
In S/HMOs, the content of interven-
tions (i.e., services offered) also changes 
with time. LTC demonstrations are often 
designed as if impairments are progres-
sive with little potential for improvement. 
LTC is viewed as "palliative." Analyses of 
national longitudinal surveys, however, 
show that many elderly, frail persons re-
gain function (Manton, Corder, and Stall-
ard, 1993; Suzman et al., 1992). Thus, out-
comes involve improvements as well as 
decrements in function. Finally, for the el-
derly, impairment is a matter of degree. At 
85 years of age, most persons may have 
an activities of daily living (ADL) or instru-
mental activities of daily living (IADL) dys-
function, though the proportion losing so-
cial autonomy, i.e., those who are wholly 
incapable of performing any self-care, is 
small (Manton et al., to be published). 
Assessments cannot simply be made of 
transitions into or out of discrete impair-
ment states. The degree of impairment on 
multiple dimensions (e.g., mobility versus 
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cognitive functioning versus manual dex-
terity) must be assessed to compare out-
comes of different care delivery systems 
over time. In this article, we examine 
whether the integration of acute and LTC 
services offered by the S/HMOs produced 
higher ALEs—periods free of impairment 
(Katz et al., 1983) —than for persons re-
ceiving customary and usual Medicare 
FFS care, controlling for differences in 
health at enrollment. 
PRIOR STUDIES OF HMOs 
Except for the 1985 HCFA S/HMO dem-
onstrations, there have been no prior 
S/HMO demonstrations. There are multi-
ple studies of the care of elderly persons 
in capitated health systems (i.e., HMOs) 
that do not provide LTC. The following cri-
teria have been used to assess HMO out-
comes. 
Most studies of Medicare HMOs exam-
ine enrollment and attrition. Riley, Rabey, 
and Kasper (1989) compared mortality 
rates for 3 HMOs with FFS for 6 years fol-
lowing enrollment, controlling for age, 
gender, and Medicaid and institutional 
status. HMO mortality was lower in the 
first year, implying favorable selection. 
Mortality increased to FFS levels by the 
second year in two plans. The third ap-
proached FFS levels over 5 years due to 
favorable attrition, i.e., mortality 2 years 
after disenrollment was higher than for 
continuing members. Two other studies 
found HMO mortality rates lower than 
FFS mortality rates. One examined mor-
tality for 2 years following enrollment 
(U.S. General Accounting Office, 1986). In 
the other study, mortality in an Oregon 
HMO was compared with State mortality 
rates over 6 years—adjusted for age, gen-
der, and smoking or non-smoking status 
(McFarland et al., 1986). These studies did 
not control for functional status. There-
fore, mortality findings are ambiguous be-
cause they can be interpreted as either an 
indirect cost measure (i.e., high terminal 
care costs) or a health measure. 
In the Medicare competition evalua-
tion, the service use of HMO and FFS cli-
ents were compared for 2 years pre-
enrollment and mortality rates were 
compared for 2 years post-enrollment. 
Prior use was lower in 13 of 14 HMOs; 
mortality lower in 12 of 17 HMOs; both re-
sults suggest favorable selection for 
HMOs. Disabled persons disenrolled 
from HMOs at higher rates (Brown, 1988). 
In addition, quality of care was assessed 
(Langwell and Hadley, 1989). Care access 
(controlled for self-reported symptoms) 
was measured by whether a health pro-
fessional was seen, and baseline and fol-
lowup health status were compared for all 
clients. No significant differences were 
found between HMOs and FFS regarding 
care access or health change. HMO 
records were more complete, and con-
tained more reports on tests and immuni-
zations. There were few differences in 
drugs prescribed, history taking, or ex-
ams for those with congestive heart fail-
ure. Some practice patterns varied (e.g., 
HMO physicians hospitalized unstable 
angina cases more often). Though an im-
provement over assessing mortality dif-
ferences, the quality of care indexes are 
partly confounded with service use. None 
of the HMO studies examined functional 
change as an outcome. 
CASE SELECTION 
Our analysis included all enrol lees in 4 
S/HMOs (n = 10,838) in June 1986 (in 
Long Beach, California and Portland, Ore-
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gon) or December 1986 (in Brooklyn, New 
York and Minneapolis, Minnesota), and 
samples (n = 16,664) of non-institution-
alized Medicare FFS clients 65 years of 
age or over living in those 4 areas. FFS cli-
ents enrolling in HMOs during the study 
were followed. This HMO group of clients 
(i.e., persons self-selected after 1986) dif-
fers from 3 HMO samples of 1,000 per-
sons each enrolling in HMOs from Medi-
care FFS in 1985 and 1986. Data collected 
on the HMO samples included a health 
screening form (HSF), prior costs (Manton 
et al., 1994), reasons for enrollment (New-
comer, Harrington, and Friedlob, 1990), 
and mortality and disenrollment (Manton 
et al., unpublished), but did not include 
health changes or post-enrollment ser-
vice use. Those data were obtained for all 
members in the FFS samples—including 
persons entering HMOs during the study. 
Thus, the HMO samples were not ana-
lyzed, but FFS clients shifting to HMOs 
during the study were. 
This evaluation is designed to assess 
the differences between S/HMOs and 
standard FFS care, and not those be-
tween S/HMOs and HMOs. During the 
demonstration, the benefits which distin-
guish S/HMOs from HMOs which provide 
extended care were reduced (Newcomer, 
Preston, and Harrington, 1991). Nonethe-
less, S/HMOs provide LTC services which 
are not reimbursed in extended care 
Medicare HMOs. Thus, changes in 
S/HMO benefits were not structural, but 
specific management decisions as serv-
ice costs became clear. Data were col-
lected to assess how S/HMO services 
changed relative to HMO services. 
Persons applying to a S/HMO could be 
nursing home certifiable under State 
Medicaid criteria, but could not be in a 
nursing home. They may have previously 
been in a nursing home, or be considering 
entering a home. Consequently, nursing 
home residents are also out of scope for 
FFS samples. This exclusion's effect var-
ies by age and gender. Nursing home resi-
dence is about 25 percent for persons 85 
years of age or over, according to the 1985 
National Nursing Home Survey (Hing, 
Sekscenski, and Strahan, 1989). Rates are 
higher for females and the oldest-old, and 
vary by health (e.g., about 45 percent of 
nursing home residents in 1985 had "de-
mentia"). Thus, the exclusion differenti-
ally affects females, the very old, and per-
sons with specific medical problems. 
Response Rates and Biases 
Non-response in the FFS sample can 
bias estimates of case-mix distributions. 
The FFS response rate for the HSF was 
80.5 percent. The HSF response rate was 
98.3 percent for S/HMOs because plans 
were required to screen persons before 
enrollment, though small numbers of en-
rollees initially received a comprehensive 
assessment form (CAF) if impairments 
were known to exist. Several persons died 
while applying. Thus, instead of defining 
S/HMO enrollees as only those with 
HSFs, persons were counted if they had 
received CAFs, had Medicare service use 
data, and were identified on Medicare 
records as a S/HMO enrollee. 
Studies of health surveys (National 
Center for Health Statistics, 1966; Man-
ton, Stallard, and Woodbury, 1991) find 
that elderly non-respondents are frailer 
and use more services than respondents. 
This is assessed in the evaluation by com-
paring the average costs of all Medicare-
eligible persons in the catchment area to 
the average costs of FFS sample respon-
dents. The average costs for the Medicare 
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population (after institutionalized per-
sons are removed) are 15 percent higher 
than those for sample respondents. Be-
cause Medicare costs are correlated with 
health and functional status, this sug-
gests that FFS sample respondents are, 
on average, healthier and less impaired 
than the total Medicare population in 
each site (Manton et al., 1994). This bias 
should be against demonstrating favor-
able enrollment in S/HMOs. In addition, 
there is a "guaranteed" time bias in that 
terminally ill persons (those with an aver-
age of 3 months to live) are unlikely to 
change care providers, i.e., enroll in 
S/HMOs. To eliminate the comparable 
group from the FFS sample, we identified 
persons who died before the end of the in-
terview period from Medicare records and 
divided them into two groups. FFS non-
respondents dying before the median in-
terview date (about 6 months; n = 765) in 
a site were excluded as terminal cases. 
Persons dying after that date are included 
and their characteristics imputed from 
the characteristics of respondents. This 
adjustment is most important for prior 
cost analyses (Manton et al., 1994). The vi-
tal status of all persons was determined 
from Medicare records. S/HMO and HMO 
enrollment and disenrollment dates were 
determined from group health member-
ship files mapped to Medicare Auto-
mated Data Retrieval System files con-
taining data on Medicare Part A and B 
service use. 
Health Assessments 
The initial assessment was a telephone-
delivered HSF for the FFS sample and a 
self-completed mail-back HSF for S/HMO 
applicants. The HSF is based on the Na-
tional Long-Term Care Survey (NLTCS) 
screening instrument (Durako, 1987). 
HSFs measure ADLs (e.g., toi let ing, 
dressing, bathing [Katz and Akpom, 
1976]), lADLs (e.g., preparing meals, laun-
dry, housework [Lawton and Brody, 
1969]), and health conditions (e.g., diabe-
tes, hypertension). Persons having two or 
more IADL (or one or more ADL) limita-
tions received a CAF, administered by so-
cial workers or nurses to verify self-
reported impairment. 
FFS cases with no ADL and fewer than 
two IADL impairments were contacted 
annually by phone. S/HMO enrollees were 
contacted by mail-back questionnaires. 
S/HMO disenrollees were interviewed 
over the phone by evaluation staff. Per-
sons reporting two or more IADL limita-
tions at baseline or in the annual re-HSF 
were contacted semiannually. Those with 
two or more IADL, but no ADL, limitations 
were given a re-HSF. Those ever reporting 
an ADL impairment are given a re-CAF— 
usually by phone. CAFs were conducted 
for 3,234 (11.8 percent) of 27,482 FFS and 
S/HMO members. In 3 years, 8,506 CAFs 
were administered—an average of 2.63 
extra contacts per interviewee. S/HMOs 
could identify health changes in clinical 
encounters. In FFS, clinical encounters 
did not trigger a CAF—the identification 
of health changes depended on a peri-
odic, but complete, screening. In S/HMOs, 
screening after enrollment started about 
6 months late and relied on mail-back in-
struments. Thus, it is less likely to be 
complete than the followup screening of 
FFS members by phone. CAFs may affect 
S/HMO service eligibility, which might 
cause bias toward recording less impair-
ment (or more improvement). 
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Case-Mix Scores 
Case-mix scores are calculated using 
grade of membership (GoM), a generaliza­
tion of log linear (Bishop, Fienberg, and 
Holland, 1975) and latent class member­
ship (LCM) (Lazarsfeld and Henry, 1968) 
analyses for categorical data. In log linear 
models, the membership of each person 
denoted by i in K independent groups is 
observed. That is, K group membership 
variables, gik (= 1 or 0), are observed, 
where gik describes whether individuals' 
observed characteristics relate to group 
Ks. For the K groups, cell probabilities for 
J-way tables, λkjl, are calculated from ob­
served frequencies; thus, the λkjls define 
the groups. In LCM, group membership is 
not observed, so the probability of being 
in a group (P(x002C6)ik = Prob[gik = 1.0]) is esti­
mated jointly with the λkjls. In GoM, not 
only is group membership unobserved, 
but persons may be "partial" members of 
groups. The giks in GoM representing par­
tial membership are estimated such that 
[inline Equation], and 0.0 ≤ gik ≤ 1.0, so that 
multiplying λkjls by giks reproduces the 
observed frequencies. Thus, GoM is used 
in this analysis to define a set of K case-
mix classes from a series of health and 
functioning variables. The relation of per­
son
 is health characteristics to the K 
classes is summarized in the K scores glk. 
The giks in GoM define within-group het­
erogeneity not represented in the LCM. 
The significance of this heterogeneity 
can be tested by determining if the GoM 
fits the data better because the models 
are parametrically nested. 
GoM was applied to pooled HSF and 
CAF data so that giks could be updated 
for health changes. The updated scores 
(gik•t) control for health variation, over indi­
viduals and time (t), in comparing S/HMO 
and FFS outcomes. In "pre-post" analy­
ses, interventions are made at fixed times 
and do not describe systems with volun­
tary enrollment or disenrollment (such as 
S/HMOs) well, where interventions are of 
variable content, duration, and timing. 
Variables affecting choice interact with 
outcome—the decision to stay enrolled 
is made daily, and reflects the degree of 
satisfaction with services and outcomes. 
In GoM, J multinomial variables for 
each of I persons (xij) are each coded as Lj 
binary (0,1) variables, yijl. Continuous vari­
ables are divided into Lj intervals and then 
coded in binary form. The probability of 
yijl occurring is (site and coverage indexes 
suppressed), 
Both the λkjl, and the gik are uniquely iden­
tified if J >2K (Woodbury, Manton, and 
Tolley, to be published), because select­
ing J variables determines the space, M, 
of all possible responses, yijl. The solu­
tion, B, is the intersection of the probabil­
ity space, LB, defined by the pijl•t esti­
mated in equation 1, with the a priori 
determined M. Extreme points of B define 
the λkj l. The giks are the linear functions 
joining λkjls. The λkjl, are assumed time in­
variant; time is represented in gik•t. 
To assure g ik•ts are comparable be­
tween FFS and S/HMO and over time, the 
K profiles (λkjl) are estimated from HSF 
and CAF data pooled over time, site, and 
coverage. The likelihood for the com­
bined data is (+ indicates a index for 
which data is combined), 
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where measurement is at time t, c refers 
to coverage (e.g., S/HMO or FFS), and s to 
site (Manton et al., 1986; 1987). A person is 
given a CAF when a health change is de-
tected in an annual re-HSF, semiannual 
monitoring of impaired persons, or in an 
S/HMO clinical visit. Because scores 
change at variable times, we divided each 
record into months (i.e., t = 1,2,…, 36). If a 
CAF is administered at t +1, new gik•t+1s 
are calculated if health changed. Other-
wise the gik•t are assumed constant. By 
using monthly histories we can estimate 
the time spent in specific health states 
(i.e., having specific gik•t values). This 
deals with the variable assessment times, 
because how long a person remains in a 
case-mix class is decribed by the gik•t. 
The GoM likelihood in equation 2 (sup-
pressing indexes for coverage, time, and 
site) is evaluated by iteratively solving two 
functions (Woodbury and Clive, 1974), 
Normally, terms in a likelihood for indi-
viduals are collected in an independent 
factor and only structural parameters (i.e., 
those not involving i) are estimated (Cox 
and Hinkley, 1974). To factor individual 
from structural parameters, assumptions 
are made about the distribution of individ-
ual parameters so that the information in 
structural parameters is restricted to a 
"small" number of data moments (e.g., 
the [J × (J +1)]/2 unique elements in a co-
variance matrix for J variables in factor 
analysis). In equation 3, estimation of gik 
involves λkjl. In equation 4 estimation of 
λkjl involves gik. Thus, the sets of param­
eters are jointly estimated. This makes 
λkjl, estimates robust to individual varia­
tion because they are conditioned on the 
gik distribution. Estimates of giks do not 
have a prespecified distribution but pro­
duce unbiased estimates of up to the Jth 
order moments of the gik distribution (Woodbury, Manton, and Tolley, to be 
published). The λkjl estimates are consis­
tent because equation 3 implicitly con­
strains the moments of the gik distribu­
tion across individuals. 
To estimate parameters for external 
variables (for validation), or transition 
rates, two steps are needed. First, equa­
tions 3 and 4 are maximized for J health 
variables. Then, the parameters for the J 
variables in equations 3 and 4 are fixed to 
hold constant the definition of the K 
classes (i.e., λkjl) and individual scores (i.e., gik). Then equation 4 is maximized to 
produce conditional (on case mix) maxi­
mum likelihood estimation of λknl for the 
N added variables. Likelihood ratio tests 
can be formed to determine if external 
variables contain significant information 
not represented in case-mix groups. Mor­
tality and coverage change probabilities 
may be estimated by defining transition 
variables for each case-mix group, i.e., 
λkN(l1• l2) (/1 are time intervals, and /2 
changes in status). Transition rates are 
estimated in a second maximum likeli­
hood step again with the definition of 
case-mix groups fixed. The λkN(l1•l2) de-
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scribe discrete changes (e.g., death, cov­
erage change) over 3 years of followup. 
They do not describe cohort changes. 
Active Life Expectancy 
The gik•t and λkjl describe all informa­
tion on health and mortality in 3 years of 
followup of an initially non-institutional­
ized population. They do not describe 
age-specific survival and disability chang­
es for a cohort of such persons. This re­
quires solving systems of difference 
equations for monthly intervals, to ap­
proximate life table differential (contin­
uous time) equations. In those calcula­
tions, two additional equations are 
needed. The first describes health chang­
es among survivors t to t +1: 
where {Age • βkk} is a matrix of age-
dependent transition rates between K 
case-mix groups. Four βkk matrices are 
estimated, one each for FFS and S/HMO 
males and females. The definition of gik•ts 
in equation 2 ensures their comparability 
over gender, coverage, and site (Manton, 
Woodbury, and Tolley, 1994). 
The second describes mortality as an 
age-dependent quadratic function of the 
gik•t, 
In equation 6 all coefficients in Q are 
multiplied by eθt. θ is the percent per year 
of age increase in mortality. In equation 6, 
a person's risk changes as gik•t changes 
according to equation 5. The performance 
of S/HMOs and FFS in maintaining func­
tion is described by βkk; and for survival 
by Qt. θ is the age-related, average effect 
of unobserved variables for FFS and 
S/HMO males and females. As informa­
tion in gik•t increases, θ 0.0 (Manton et 
al., to be published). 
Calculating cohort life tables requires 
using parameters in equations 5 and 6 to 
solve monthly difference equations. The 
proportion of a cohort, /, surviving to t +1, 
is, 
where g(inline equation) (t) is a vector of means of gik•t and 
Vt their covariance matrix. Equations 8 
and 9 show that g(inline equation)*(t) and (V*t) are func­
tions of mortality(Qt) and case mix heter­
ogeneity (Vt) or, 
and 
Mortality depends on g(x00304)(t and Vt. Vt has 
deterministic (i.e., Age • βkk) and stochas­
tic components. Diffusion increases, and 
mortality reduces, Vt. Diffusion must re­
flect the 0,1 bounds on the gik•ts. We as­
sume that Vt has, at most, Bernoulli vari­
ance, (inline equation)), and that 
correlations of gik•ts are constant from t to 
t + 1 . The correlation matrix R is esti­
mated from Vt after conditioning on age. 
In the diagonal matrix, S, elements are 
square roots of the ratios of gik•t variances 
to Bernoulli limits. S projects the gik•t to a 
high dimensional spherical space so that, 
in computations, gik•ts are not "trapped" 
on "faces" of B. W t+1 is a diagonal matrix 
with elements 
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The new "constrained" variance is 
which can be used to estimate a con­
strained diffusion matrix, 
where Ct = Age • βkk from equation 5. 
Changes in the means (inline equation) of gik•tfor sur­
vivors are 
Equations 7 through 12 are used to cal­
culate cohort life tables for K case-mix 
groups. Cohort life tables differ from tran­
sition variables estimated in equation 2 
because the 3-year experience of initially 
non-institutionalized persons of different 
ages is used to construct disability dy­
namics and mortality for the life of a co­
hort. Thus, there are three distinct sets of 
calculations. One generates the gik•t, de­
scribing cases from the pooled data us­
ing equation 2. In those calculations we 
may estimate 3-year transition rates. Sec­
ond, gik•ts are used to generate parame­
ters for disability dynamics (in equation 5) 
and mortality (in equation 6). Those pa­
rameters are used in difference equations 
7 through 12 to calculate cohort life ta­
bles. The individual components of co­
hort dynamics can be examined by fixing 
selected parameters in equations 7 
through 12. 
In a hazard model, the risk of an event is 
estimated for fixed covariates (Cupples et 
al., 1988). The difference equations use 
time-varying covariates. Thus, the differ­
ence equations produce insights about 
cohort dynamics that cannot be made us­
ing only a hazard function. The quadratic 
in equation 6, one component of the co­
hort calculations, is a hazard function. It 
is estimated by maximum likelihood and, 
because u. (the mortality rate) is estimated 
directly, there are no problems of inter­
preting coefficients as in Cox or logistic 
functions (e.g., including quadratic terms 
in a Cox model makes the hazard scale 
dependent)—the function changes as 
risk factor levels change. 
RESULTS 
To assess FFS or S/HMO outcomes, 
health variation over persons and time 
must be described. This requires defining 
multiple "Profiles" to characterize a per­
son's health. The six profiles in Table 1 
are described by comparing λkjls to the 
overall frequency of an attribute—e.g., 
27.1 percent need help with meals. Some­
one who "fits" Profile 3,4, or 6 (i.e., has a 
high gik•t) requires assistance. Individuals 
matching Profiles 1,2, or 5 do not. The λkjl, 
can be discussed both as a profile of J at­
tributes and as groups of cases character­
ized by a profile. 
The profiles in Table 1 are defined by 
their association (λkjt) with health vari­
ables: 
• "Healthy"—Individual is unimpaired 
but has diabetes, hypertension, and 
joint disease. This profile is "healthy" 
relative to other case-mix groups. 
• "Acutely III"—Individual has cancer 
(100 percent), cardiopulmonary prob­
lems, and hypertension, but no impair­
ment. 
• "Impaired"—Individual has IADL im­
pairments suggesting early dementia 
but few other neurological problems. 
Medical conditions (e.g., diabetes) may 
be present. 
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Table 1 
Multivariate Values for 30 Health and Functioning Measures From Social/Health 
Maintenance Organization (S/HMO) Demonstrations: 1986-89 
Health and Functioning Measures 
Functional Ability 
Requires Assistance With: 
1. Preparing Meals 
2. Laundry 
3. Light Housework 
4. Grocery Shopping 
5. Managing Money 
6. Taking Medicine 
7. Making Phone Calls 
8. Eating 
9. Getting In and Out of Chairs or Bed 
10. Walking Around Inside 
11. Driving or Using Public Transportation 
12. Toileting 
13. Dressing 
14. Bathing 
Individual: 
15. Uses a Wheelchair or Walker 
16. Uses a Cane 
17. Is Bedfast 
Medical Conditions 
18. Diabetes Mellitus 
19. Hypertension 
20. Heart Trouble 
21. Neurological Problems 
22. Stroke 
23. Lung or Breathing Problems 
24. Chronic Cough 
25. Cancer 
26. Hardening of the Arteries 
27. Stomach or Bowel Problems 
28. Bladder Problems 
29. Rheumatism or Arthritis 
30. Other Health Problems 
gk (weighted prevalence) 
Frequency 
27.1 
19.9 
16.3 
15.8 
21.2 
14.8 
11.4 
7.9 
22.2 
15.7 
32.3 
20.3 
16.2 
20.9 
6.7 
18.0 
13.2 
17.6 
31.7 
18.6 
11.2 
17.0 
18.9 
6.8 
16.3 
14.6 
20.9 
15.5 
56.7 
25.2 
— 
Healthy 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
100.0 
27.6 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
41.0 
11.6 
52.2 
Acutely 
III 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
100.0 
0.0 
100.0 
100.0 
0.0 
100.0 
100.0 
0.0 
0.0 
100.0 
0.0 
100.0 
0.0 
100.0 
96.5 
7.0 
Case-M 
Impaired 
Percent 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
86.5 
0.0 
0.0 
0.0 
100.0 
0.0 
0.0 
0.0 
38.5 
0.0 
0.0 
100.0 
29.7 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
26.4 
9.8 
ix Group 
Pulmonary 
100.0 
0.0 
0.0 
0.0 
42.1 
0.0 
0.0 
0.0 
100.0 
0.0 
100.0 
100.0 
100.0 
100.0 
0.0 
0.0 
42.2 
0.0 
0.0 
0.0 
0.0 
0.0 
80.8 
0.0 
49.8 
0.0 
0.0 
44.4 
53.5 
30.8 
11.7 
Cardiac 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
100.0 
100.0 
100.0 
0.0 
0.0 
100.0 
73.5 
0.0 
100.0 
100.0 
100.0 
100.0 
71.6 
11.5 
Frail 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
89.2 
75.9 
100.0 
100.0 
46.2 
0.0 
100.0 
0.0 
0.0 
0.0 
40.8 
47.7 
0.0 
0.0 
10.0 
0.0 
38.6 
0.0 
63.9 
36.5 
7.8 
SOURCES: Data derived from health screening forms (HSFs) and comprehensive assessment forms (CAFs) administered by the authors. 
HSF data were collected from fee-for-service beneficiaries at baseline and from S/HMO enrollees upon application. Total HSF sample size is 
27,503 cases. CAFs were completed semiannually by persons who identified functional disabilities on the HSF. 
• "Pulmonary"—Individual has ADL im-
pairments (42.2 percent bedfast), pul-
monary problems (80.8 percent), and 
cancer (49.8 percent). 
• "Cardiac"—Individual is not impaired, 
but has multiple medical problems—in-
cluding cardiopulmonary conditions 
(no stroke) and arteriosclerosis. 
• "Frail"—Individual is bedfast (100 per-
cent) and limited on all ADLs and 
lADLs. Medical problems include 
stroke, cancer, neurological, stomach, 
and bowel problems. A person with a 
high score on this dimension, unless 
having excellent social and economic 
resources, would be at risk of institu-
tionalization because he or she is 88.9 
percent impaired on the 17 functional 
items. Thus, as the population ages, 
movement into the frail category serves 
as a measure of persons potentially 
needing institutionalization—because 
182 HEALTH CARE FINANCING REVIEW/Winter1993/volume 15, Number 2 
institutional residents were excluded at 
the study's start and are not repre­
sented in baseline health measures. 
The predictive validity of the g ik• t was 
examined on sociodemographics and 
service use (Reuben, Siu, and Kimpau, 
1992). The λ k N l s describing these rela­
t ions (calculated condi t iona l ly on 
case-mix scores) are presented in Table 2. 
Approximately 93.6 percent of the 
"healthy" group report good or excellent 
health; 100 percent of the "acutely i l l " 
group report fair or poor health. Persons 
in the "impaired" group (48.9 percent re­
porting fair or poor health) are similar to 
those in the "pulmonary" group (38.3 per­
cent), while the "cardiac" (65.2 percent 
fair or poor) and "frail" (60.1 percent fair or 
poor) groups are similar. Case mix is not 
strongly associated with age because 
health changes (gik•t) estimated from the 
combined HSF and CAF data, represent 
most age effects. Healthy individuals are 
young—a mean age of 71.7. The frail 
group members are the oldest, with a 
mean age of 83.2. Acutely ill persons are 
older (77.5) than the healthy, but are little 
different than the two chronically ill 
groups. 
There are also large differences in ser­
vice use. Acutely ill individuals use the 
most acute care (e.g., oxygen, 10.6 per­
cent; visiting nurses, 11.2 percent; home 
health aides, 22.7 percent), and 100 per­
cent had prior hospital stays. Prior hospi­
tal use for the impaired and pulmonary 
groups is similar—and three times that of 
the healthy group. Hospital use in the car­
diac and frail groups is similar; the frail 
group used the most nursing homes, vis­
iting nurses, home health, and transport 
services. These groups are similar to 
those produced from the baseline HSF 
data(Manton et al., 1994). In the combined 
HSF and CAF data, the pulmonary group 
is more impaired and the cardiac group 
has more medical problems—as does the 
acutely ill group. Because new health 
problems are recorded on CAFs, the num­
ber of disabilities and medical problems 
generally increased. 
Health Status, Mortality, and 
Disenrollment 
One-year probabilities of change in cov­
erage and mortality for case-mix groups 
estimated from transit ion variables 
ΛKN(l1•l2)are in Table 3. The HMO category 
represents the experience of FFS clients 
(n = 900) entering an HMO during the 
study. 
Health Assessment 
A CAF is used to assess health chang­
es. For S/HMO members this may occur 
after a clinical encounter. In the FFS eval­
uation, data were not collected on clinical 
encounters. Instead, a re-HSF or re-CAF 
is given every 6 months to impaired per­
sons, and everyone is screened annually. 
It is unlikely that changes in chronic dis­
abilities are missed in a 6-month interval 
(Manton, Vertrees, and Clark, 1993). 
Healthy (3.6 percent) and acutely ill (6.6 
percent) S/HMO enrollees have a greater 
(but still relatively insignificant) chance of 
receiving a CAF than FFS sample mem­
bers. S/HMO and FFS CAF rates are simi­
lar for impaired groups. Frail HMO mem­
bers have CAF rates similar to FFS and 
S/HMOs. The largest S/HMO and FFS dif­
ferences are for chronically ill groups. 
Though S/HMOs have a higher case-mix 
adjusted probability of a CAF than FFS 
(i.e., 38 percent versus 21.8 percent), the 
HEALTH CARE FINANCING REVIEW/Winter 1993/volume 15,Number2 183 
Table 2 
Multivariate Values for Sociodemographic and Health Service Use Variables From 
Social/Health Maintenance Organization (S/HMO) Demonstrations: 1986-89 
Variables 
Sociodemographic Variables 
Gender: 
Male 
Female 
Age: 
64-69 Years 
70-74 Years 
75-79 Years 
80-84 Years 
85-89 Years 
90 Years or More 
Mean Age 
Marital Status: 
Married 
Not Married 
Living Arrangements: 
Lives Alone 
With Spouse 
With Child 
With Relative 
With Unrelated Person 
Type of Housing: 
Group Care 
Senior Housing 
Other's Home 
Own Home 
Other 
Self-Rated Health: 
Excellent 
Good 
Fair 
Poor 
Health Service Use Variables 
Oxygen Equipment 
Visiting Nurse Services 
Therapist Services 
Home Health Aide Services 
Social Worker Services 
Adult Day Health Services 
Transportation Assistance 
Meals Delivered to Home 
Hospital Admissions in Past Year: 
None 
1-3 
4 or More 
Nursing Home Use: 
None 
1-30 Days 
31 Days or More 
Considering Applying to 
Nursing Home 
Frequency 
37.4 
62.6 
33.4 
22.1 
17.4 
14.2 
8.9 
4.0 
75.3 
51.3 
48.7 
36.0 
50.6 
7.0 
3.4 
3.1 
1.4 
4.5 
4.4 
88.5 
1.3 
23.4 
46.8 
23.0 
6.8 
1.8 
3.5 
1.4 
5.0 
2.3 
1.1 
7.1 
3.4 
76.8 
22.0 
1.2 
99.1 
0.4 
0.5 
1.2 
Healthy 
43.1 
57.0 
54.0 
22.8 
13.3 
7.6 
1.9 
0.5 
71.7 
58.7 
41.3 
33.5 
57.8 
4.5 
2.7 
1.5 
0.3 
2.7 
2.1 
93.8 
1.1 
36.8 
56.8 
6.5 
0.0 
0.0 
0.1 
0.3 
0.2 
0.1 
0.2 
0.5 
0.4 
89.1 
10.8 
0.1 
99.9 
0.1 
0.0 
0.3 
Acutely IIl 
34.9 
65.1 
0.0 
0.0 
100.0 
0.0 
0.0 
0.0 
77.5 
12.5 
87.5 
69.3 
11.5 
12.7 
5.4 
1.0 
0.0 
17.9 
7.3 
72.1 
2.7 
0.0 
0.0 
73.9 
26.1 
10.6 
11.2 
8.7 
22.7 
17.3 
1.6 
58.1 
16.6 
0.0 
90.0 
10.0 
96.5 
3.3 
0.3 
3.6 
Case-M 
Impaired 
Percent 
40.4 
59.7 
5.0 
66.1 
7.0 
9.4 
6.5 
6.1 
75.8 
43.9 
56.1 
24.5 
42.8 
18.4 
5.6 
8.7 
6.4 
4.8 
20.4 
67.0 
1.5 
10.4 
40.7 
31.6 
17.3 
6.6 
9.5 
2.9 
12.6 
4.9 
3.1 
20.2 
11.8 
67.9 
30.0 
2.1 
97.7 
0.8 
1.5 
4.5 
ix Group 
Pulmonary 
25.3 
74.7 
10.2 
11.5 
7.4 
55.5 
11.0 
4.5 
80.5 
36.0 
64.1 
47.0 
36.8 
7.2 
5.1 
3.9 
4.5 
5.1 
6.1 
83.7 
0.6 
11.5 
50.3 
29.7 
8.5 
3.2 
8.9 
2.2 
12.8 
4.3 
1.6 
17.4 
9.2 
71.8 
27.1 
1.1 
99.1 
0.4 
0.5 
1.4 
Cardiac 
28.0 
72.0 
16.5 
14.7 
13.2 
12.6 
42.5 
0.5 
80.1 
41.1 
58.9 
51.4 
40.1 
4.3 
1.7 
2.5 
0.1 
9.4 
2.3 
86.4 
1.8 
0.1 
34.7 
57.4 
7.8 
4.2 
0.6 
0.9 
1.5 
0.7 
0.9 
4.9 
3.0 
60.7 
36.9 
2.5 
99.7 
0.2 
0.1 
0.6 
Frail 
29.4 
70.6 
11.0 
10.0 
13.3 
16.8 
17.0 
31.9 
83.2 
55.7 
44.3 
1.3 
55.1 
16.0 
6.0 
10.8 
4.4 
3.0 
8.3 
82.1 
2.3 
7.5 
32.4 
30.7 
29.4 
2.9 
17.5 
5.2 
22.5 
9.8 
5.2 
13.1 
7.1 
65.2 
32.3 
2.6 
94.5 
1.4 
4.1 
5.1 
SOURCES: Data derived from health screening forms (HSFs) and comprehensive assessment forms (CAFs) administered by the authors. 
HSF data were collected from fee-for-service beneficiaries at baseline and from S/HMO enrollees upon application. Total HSF sample size is 
27,503 cases. CAFs were completed semiannually by persons who identified functional disabilities on the HSF. 
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case-mix weighted time between CAFs is 
38.4 days shorter in FFS. 
CAF rates for S/HMOs may be higher in 
the healthy, acutely and chronically ill 
groups because of a greater likelihood of 
clinical encounters for acute conditions. 
A CAF, however, is needed to qualify for 
LTC. Frail cases enrolled in S/HMOs, at 
baseline, were more severely ill and 
younger than in FFS. Though not likely to 
stay frail (i.e., to recover or die), they had 
high initial costs (Manton et al., unpub-
lished). Thus, despite the higher S/HMO 
CAF rates, it is unclear that clinical en-
counters uncover more chronic disability 
than the periodic and comprehensive FFS 
screening. 
Changes in Coverage 
This category includes persons who 
moved from: FFS to an HMO; an S/HMO 
(or HMO) to another HMO; an S/HMO (or 
HMO) to FFS. Annually, 15.2 percent of 
FFS clients enroll in HMOs; 10.6 percent 
Table 3 
Annual Functional Impairment, Coverage Change, and Mortality Probabilities, 
by Case-Mix Group and Health Coverage: 1986-89 
Case-Mix Group and 
Health Coverage 
Case-Mix Standardized Rate 
S/HMO 
FFS 
HMO2 
Healthy 
S/HMO 
FFS 
HMO2 
Acutely III 
S/HMO 
FFS 
HMO2 
Impaired 
S/HMO 
FFS 
HMO2 
Pulmonary 
S/HMO 
FFS 
HMO2 
Cardiac 
S/HMO 
FFS 
HMO2 
Frail 
S/HMO 
FFS 
HMO2 
Health 
Assessment1 
38.0 
21.8 
18.4 
3.6 
1.2 
0.5 
6.6 
1.0 
1.2 
75.4 
76.1 
28.2 
80.9 
56.9 
46.7 
40.1 
7.6 
6.9 
78.8 
70.2 
78.9 
S/HMO 
— 
0.9 
0.4 
— 
1.2 
0.2 
— 
1.6 
0.9 
— 
0.7 
0.2 
— 
0.3 
2.4 
— 
0.7 
0.3 
— 
0.3 
0.8 
Change in Coverage 
HMO 
Percent 
3.9 
15.2 
31.9 
5.8 
20.7 
36.8 
1.8 
14.4 
34.6 
3.4 
11.2 
43.7 
1.2 
6.6 
21.2 
4.1 
16.4 
32.8 
0.6 
3.2 
5.2 
FFS 
9.4 
— 
10.6 
10.7 
— 
9.8 
27.2 
— 
16.5 
11.5 
— 
10.8 
4.9 
— 
12.6 
8.8 
— 
13.1 
3.4 
— 
9.5 
Death 
10.1 
10.2 
8.1 
3.0 
3.7 
3.0 
6.4 
9.5 
9.0 
22.1 
14.4 
12.3 
7.4 
12.1 
9.3 
8.6 
22.4 
10.9 
51.7 
28.2 
30.3 
1This column refers to the annual probability of receiving a comprehensive assessment form (CAF), issued when a change in health or a func-
tional impairment was reported. After initial issuance, a CAF was refilled every 6 months. 
2This refers to persons in either FFS or S/HMOs who entered HMOs after the start of the study. 
NOTES: S/HMO is social/health maintenance organization. HMO is health maintenance organization. FFS is fee-for-service. Probabilities are 
annualized and may not sum to 100 percent. 
SOURCES: Data derived from health screening forms (HSFs) and CAFs administered by the authors. HSF data were collected from FFS 
beneficiaries at baseline and from S/HMO enrollees upon application. Total HSF sample size is 27,503 cases. CAFs were completed 
semiannually by persons who identified functional disabilities on the HSF. 
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return to FFS. Approximately 3.9 percent 
and 9.4 percent of S/HMO members 
(case-mix adjusted) enroll in HMOs and 
return to FFS, respectively. Healthy FFS 
cases are more likely to join HMOs (20.7 
percent) than the acutely ill (14.4 percent). 
The FFS impaired (11.2 percent) and car-
diac (16.4 percent) groups are also likely 
to enter HMOs. The FFS pulmonary 
group is less likely (6.6 percent), and the 
frail least likely (3.2 percent) to enter 
HMOs. 
Approximately one-third (31.9 percent) 
of the 900 HMO enrollees switch plans 
annually—more than in baseline HMO 
samples. S/HMO members, partly be-
cause a large proportion in two sites (40 
percent and 60 percent) enrolled from the 
parent HMO, are stable (Harrington, New-
comer, and Preston, 1993; Newcomer, 
Preston, and Harrington, 1991). Among re-
cent HMO enrollees, only the pulmonary 
(21.2 percent) and frail (5.2 percent) 
groups do not switch often. Less than 6 
percent of S/HMO members in any group 
switch to HMOs. For the acutely ill or frail, 
the rate is less than 2 percent. This is con-
sistent with HMO joiners adjusting to 
new plans and S/HMO members having 
stable plan relations. 
Acutely ill S/HMO enrollees are more 
likely than HMO members to return to 
FFS (27.2 percent versus 16.5 percent), as 
are the healthy and the impaired enroll-
ees. Disenrollment varies by site. The two 
new plans disenroll more acutely ill per-
sons than S/HMOs in mature HMOs. 
There is little difference between S/HMO 
and HMO enrollees wi th respect to 
healthy and impaired groups. S/HMO 
members in the chronically ill or frail 
groups are less likely than HMO joiners to 
return to FFS. 
Mortality 
FFS mortality (gender and age com-
bined) is higher for the healthy, acutely 
and chronically ill and lower for the im-
paired groups. "Case-mix standardized" 
values are weighted to the pooled case 
mix of the S/HMO and FFS populations. 
FFS clients enrolling in HMOs had the 
lowest mortality (8.1 percent). S/HMO 
(10.1 percent) and FFS (10.2 percent) rates 
are similar. Case-mix measures estimated 
from the pooled HSF/CAF data explain 
most S/HMO and FFS mortality differ-
ences. The HSF data alone explain only 
82 percent of mortality differences. 
STOCHASTIC HEALTH CHANGES AND 
MODALITY 
The number of factors that can be si-
multaneously controlled by stratification 
is limited. Consequently we used a multi-
variate model to control for health inputs, 
gender, age, and coverage in examining 
what happens in a cohort simultaneously 
subjected to mortality and disability dy-
namics. From data available for 3 years, 
the difference equations were used to 
construct S/HMO or FFS cohort life ta-
bles. Cohort estimates reflect differences 
in initial case-mix distributions as well as 
age-dependent dynamics. To examine 
how disability and mortality interact in 
FFS and S/HMOs, we calculated three 
types of life tables. Table 5 presents the 
age-specific life expectancies and num-
ber of years expected to be lived in each 
case-mix group. In Tables 6 and 7, cohort 
health changes, mortality, and the propor-
tion expected to be active at specific ages 
are calculated—starting from specific 
groups to adjust for initial case-mix differ-
ences. In Table 8, the effects of case-mix 
dynamics are removed by starting co-
186 HEALTH CARE FINANCING REVIEW/Winter 1993/volume 15, Number 2 
horts at specific ages and, holding case-
mix constant, identifying S/HMO and FFS 
differences in mortality over age (rather 
than just at 75 years of age, as in Table 4). 
MORTALITY FUNCTIONS 
Table 4 presents gender-specific esti­
mates of FFS and S/HMO mortality (i.e., 
the Qt). All four have significant χ2. Each 
is estimated with its own θ to adjust for 
different unobserved age-related risk fac­
tors (i.e., bias). The coefficients represent 
the annual probability of death (χ 100) at 
75 years of age. Diagonal coefficients are 
the probability of death for a person in a 
case-mix group (e.g., the probability of 
death for a male whose gik = 1.0 in an 
S/HMO is 57.1 percent; in the healthy 
group, 2.9 percent). The relative risk of 
frail to healthy groups is 19.7 to 1 (com­
pared with Table 3,19.8 to 1.0; in baseline 
data the ratio is 10.5 to 1). If a person is 
represented by multiple profiles, off-
diagonal (interaction) terms are used. For 
example, the mortality for a person whose 
health status is a mixture of the attributes 
of the frail and healthy groups is the 
weighted sum of the diagonal and interac­
tion coefficients for the two groups. 
Impaired and frail males have signifi­
cantly higher mortality in S/HMOs (Table 
3). FFS mortality is higher for the acutely 
ill, cardiac, and pulmonary groups, except 
if sharing attributes with an impaired 
group, due to interactions. Because im­
pairment increases with age, this gives 
FFS males a mortality advantage at later 
ages—along with two other factors. The 
first is that θ, representing unobserved 
age-related factors, raises mortality 2.7 
percent per year for FFS males, and 3.8 
percent per year for S/HMO males. For 
each year of age, mortality rises 40.7 per­
cent faster for S/HMO males because of 
non-health factors. Second, the mortality 
ratio of frail to healthy groups is greater in 
S/HMOs (19.7 to 1) than in FFS (7.1 to 1). 
Thus, as disability dynamics move per­
sons into frail groups with age, mortality 
increases more rapidly for S/HMO males. 
For females, there are no significant 
mortality differences for the healthy, 
acutely ill, or impaired groups. Two differ­
ences for the pulmonary group are mar­
ginally significant. Significant differences 
exist for the cardiac and frail groups. 
S/HMO females in the cardiac and pulmo­
nary groups are advantaged. FFS females 
in the frail group, including its interac­
tions with all other groups (except the car­
diac), are advantaged. The interaction in­
volving the frail and pulmonary groups is 
significant, and shows a favorable effect 
for FFS females. Because the cardiac 
group is younger (mean age 80.1 years) 
and the frail older (83.2 years), FFS fe­
males will be advantaged at later ages. 
The θ shows mortality increases 12.8 per­
cent less per year as S/HMO females age. 
This is counterbalanced by disability dy­
namics moving more females with age 
into the frail group, where FFS females 
have better survival. The effects of greater 
heterogeneity (i.e., a frail-to-healthy rela­
tive risk of 20.8 to 1 versus 8.9 to 1 in FFS) 
also favors FFS female survival. 
ACTIVE LIFE EXPECTANCY ESTIMATES 
We used equations 7 through 12 to esti­
mate cohort life tables using parameters 
from equations 6 and 7. At the left of Ta­
ble 5 we list age and coverage. Next are 
age-specific life expectancies and then 
six columns containing the years ex­
pected to be lived at age χ in a case-mix 
group (ekχ)—underneath each ekχ is the 
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Table 4 
Mortality Functions, by Case-Mix Group and Health Coverage, by Gender, 
at 75 Years of Age 
Case-Mix Group 
and Health 
Coverage 
Males* 
Healthy: 
FFS 
S/HMO 
Acutely III: 
FFS 
S/HMO 
Impaired: 
FFS 
S/HMO 
Pulmonary: 
FFS 
S/HMO 
Cardiac: 
FFS 
S/HMO 
Frail: 
FFS 
S/HMO 
Females** 
Healthy: 
FFS 
S/HMO 
Acutely III: 
FFS 
S/HMO 
Impaired: 
FFS 
S/HMO 
Pulmonary: 
FFS 
S/HMO 
Cardiac: 
FFS 
S/HMO 
Frail: 
FFS 
S/HMO 
Healthy 
3.2 (±0.40) 
2.9 (±0.40) 
1.7 (±0.23) 
1.6 (±0.25) 
Acutely III 
15.7 (±0.60) 
4.3 (±0.85) 
19.9 (±1.78) 
6.2 (±2.42) 
2.8 (±0.36) 
2.7 (±0.51) 
4.7 (±0.94) 
4.6 (±1.60) 
Case-Mix 
Impaired 
15.1 (±0.63) 
6.5 (±1.54) 
8.8 (±1.26) 
9.6 (±2.74) 
17.9 (±1.78) 
14.7 (±6.80) 
3.2 (±0.34) 
3.2 (±0.85) 
5.4 (±0.69) 
5.4 (±1.66) 
6.1 (±1.02) 
6.4 (±3.38) 
Group 
Pulmonary 
6.3 (±0.68) 
6.3 (±1.08) 
111.0 (±1.38) 
9.2 (±2.14) 
19.8 (±1.41) 
14.2 (±3.72) 
12.2 (±2.20) 
13.7 (±4.24) 
13.5 (±0.33) 
3.1 (±0.51) 
5.9 (±0.69) 
5.4 (±1.17) 
6.7 (±0.70) 
6.4 (±1.74) 
17.3 (±0.96) 
6.3 (±1.75) 
Cardiac 
16.6 (±0.64) 
5.0 (±0.80) 
111.5 (±1.43) 
7.4 (±1.66) 
110.3 (±1.46) 
11.3 (±3.04) 
112.8 (±1.62) 
10.9 (±2.30) 
113.4 (±2.4) 
8.7 (±2.81) 
14.0 (±0.32) 
2.5 (±0.43) 
16.6 (±0.75) 
4.2 (±0.96) 
17.5 (±0.76) 
5.0 (±1.50) 
18.2 (±0.71) 
4.9 (±1.04) 
19.2 (±1.06) 
3.9 (±1.36) 
Frail 
18.6 (±1.04) 
12.9 (±1.57) 
115.0 (±1.96) 
18.9 (±3.8) 
113.4 (±1.97) 
29.0 (±6.9) 
116.6 (±2.20) 
28.0 (±4.9) 
117.4 (±2.30) 
22.3 (±4.2) 
122.6 (±4.60) 
57.1 (±11.4) 
15.1 (±0.45) 
7.2 (±0.85) 
18.5 (±0.96) 
12.4 (±2.32) 
19.7 (±0.97) 
14.6 (±3.86) 
110.6 (±0.91) 
14.4 (±2.24) 
11.8 (±0.96) 
11.3 (±2.22) 
115.2 (±1.77) 
33.2 (±5.66) 
*θFFS = 0.027, χ2 = 587.6, Ratio (6/1) = 7.1 
θS/HMO = 0.038, χ2 = 643.9, RR = 19.7 
* * θFFS = 0.034, χ2 = 1334.3, RR = 8.9 
θS/HMO = 0.030, χ2 = 736.8, RR = 20.8 
1FFS two standard deviation bound for coefficient does not contain S/HMO estimate. 
NOTES: FFS Is fee-for-service. S/HMO is social/health maintenance organization. Underlined rates indicate the higher of the two rates In the 
S/HMO and FFS comparison. 
SOURCES: Data derived from health screening forms (HSFs) and comprehensive assessment forms (CAFs) administered by the authors. 
HSF data were collected from FFS beneficiaries at baseline and from S/HMO enrollees upon application. Total HSF sample size is 27,503 
cases. CAFs were completed semiannually by persons who identified functional disabilities on the HSF. 
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Table 5 
Life Expectancy and Active Life Expectancy by Age, Health Coverage, and Case-Mix Group, 
by Gender 
Gender, Age, and 
Health Coverage 
Males 
65 Years: 
FFS 
S/HMO 
75 Years: 
FFS 
S/HMO 
85 Years: 
FFS 
S/HMO 
95 Years: 
FFS 
S/HMO 
Females 
65 Years: 
FFS 
S/HMO 
75 Years: 
FFS 
S/HMO 
85 Years: 
FFS 
S/HMO 
95 Years: 
FFS 
S/HMO 
Life 
Expectancy 
15.2 
14.9 
11.3 
9.6 
7.1 
5.6 
3.6 
2.7 
21.4 
18.4 
15.1 
11.9 
9.2 
6.5 
4.6 
3.4 
Healthy 
10.7 
(70.8) 
13.2 
(88.8) 
8.5 
(75.3) 
8.0 
(83.2) 
4.6 
(65.4) 
4.1 
(73.4) 
1.4 
(40.3) 
1.8 
(63.9) 
18.7 
(87.2) 
16.1 
(87.4) 
13.0 
(86.2) 
9.2 
(77.6) 
6.3 
(69.1) 
3.6 
(56.0) 
1.7 
(36.5) 
1.1 
(32.8) 
Acutely III 
0.2 
(1.6) 
0.4 
(2.6) 
0.4 
(3.2) 
0.3 
(2.8) 
0.2 
(2.9) 
0.2 
(4.0) 
0.3 
(8.6) 
0.2 
(7.3) 
0.5 
(2.3) 
0.5 
(2.8) 
0.2 
(1.6) 
0.3 
(2.3) 
0.2 
(1.9) 
0.2 
(3.1) 
0.3 
(6.0) 
0.3 
(7.4) 
Case-Mix 
Impaired 
0.1 
(0.8) 
0.1 
(1.0) 
0.5 
(4.0) 
0.1 
(1.5) 
0.5 
(7.7) 
0.1 
(2.3) 
0.2 
(5.6) 
0.1 
(2.1) 
0.4 
(2.0) 
0.3 
(1.6) 
0.3 
(2.2) 
0.2 
(2.1) 
0.6 
(6.1) 
0.3 
(4.8) 
0.2 
(5.2) 
0.2 
(6.9) 
Group1 
Pulmonary 
1.4 
(9.4) 
0.1 
(1.0) 
0.6 
(5.0) 
0.4 
(4.0) 
1.0 
(14.3) 
0.5 
(9.5) 
0.7 
(18.2) 
0.1 
(4.3) 
0.2 
(1.1) 
0.1 
(0.3) 
0.6 
(4.0) 
0.9 
(7.5) 
1.5 
(15.9) 
1.3 
(19.8) 
0.9 
(19.1) 
0.9 
(26.7) 
Cardiac 
2.3 
(15.2) 
0.9 
(6.0) 
1.2 
(11.0) 
0.6 
(6.0) 
0.4 
(6.3) 
0.3 
(5.5) 
0.4 
(10.2) 
0.2 
(6.6) 
1.4 
(6.6) 
1.3 
(7.3) 
0.6 
(4.2) 
1.0 
(8.3) 
0.3 
(3.6) 
0.6 
(8.7) 
0.4 
(8.5) 
0.2 
(5.0) 
Frail 
0.3 
(2.2) 
0.1 
(0.7) 
0.1 
(1.0) 
0.2 
(2.5) 
0.2 
(3.5) 
0.3 
(5.4) 
0.6 
(17.1) 
0.4 
(15.8) 
0.1 
(0.7) 
0.1 
(0.6) 
0.3 
(1.9) 
0.3 
(2.2) 
0.3 
(3.5) 
0.5 
(7.6) 
1.1 
(24.7) 
0.7 
(20.4) 
1Years of life expectancy at age X and proportion surviving. 
NOTES: FFS is fee-for-service. S/HMO is social/health maintenance organization. Numbers in parentheses are in percent. 
SOURCE: Data derived from health screening forms (HSFs) and comprehensive assessment forms (CAFs) adminstered by the authors. HSF 
data were collected from FFS beneficiaries at baseline and from S/HMO enrollees upon application. Total HSF sample size is 27,503 cases. 
CAFs were completed semiannually by persons who identified functional disabilities on the HSF. 
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Table 6 
Health and Mortality Variables for Males at 75 and 85 Years of Age, by Case-Mix Group at 65 Years of Age 
Age at 
Evaluation 
75 Years 
85 Years 
Case-Mix 
Group at 65 
Years of Age 
Healthy 
Acutely III 
Impaired 
Pulmonary 
Cardiac 
Frail 
Healthy 
Acutely III 
Impaired 
Pulmonary 
Cardiac 
Frail 
Health 
Coverage 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
Life 
Expectancy 
12.5 
9.8 
9.9 
8.3 
10.9 
7.8 
9.3 
8.5 
8.5 
7.5 
9.3 
8.4 
7.4 
5.6 
6.7 
5.5 
7.0 
5.5 
6.6 
5.5 
6.4 
5.3 
6.6 
5.5 
Proportion 
Surviving -
in Percent 
73.9 
71.0 
46.2 
41.0 
57.2 
25.9 
38.1 
33.3 
35.1 
40.2 
31.7 
15.5 
44.2 
32.0 
20.4 
14.5 
28.9 
8.4 
15.4 
12.1 
12.4 
11.8 
12.8 
5.6 
Healthy 
94.3 
88.3 
47.3 
56.9 
66.2 
49.9 
37.6 
61.7 
25.3 
22.8 
37.3 
57.9 
75.2 
74.5 
53.7 
69.8 
62.1 
69.3 
49.5 
70.3 
42.0 
58.8 
49.5 
69.1 
Case-Mix Group 
Acutely III 
1.1 
2.2 
6.7 
14.8 
4.7 
6.3 
7.9 
6.2 
5.9 
3.9 
8.1 
8.5 
2.2 
3.8 
3.6 
4.8 
3.1 
4.7 
3.9 
4.5 
4.3 
5.4 
3.9 
4.6 
Impaired 
0.8 
1.1 
14.9 
3.8 
11.4 
23.0 
11.3 
3.6 
7.9 
3.4 
11.6 
3.3 
5.0 
2.2 
12.2 
2.6 
9.9 
2.9 
12.4 
2.5 
12.2 
3.3 
12.5 
2.6 
at Evaluation 
Pulmonary 
1.8 
3.5 
9.9 
9.6 
6.6 
6.8 
14.0 
11.0 
10.4 
6.7 
14.4 
8.8 
12.4 
9.4 
16.5 
10.2 
14.9 
10.1 
17.6 
10.0 
18.0 
10.8 
17.7 
10.1 
Age 
Cardiac 
1.5 
2.9 
17.7 
9.4 
8.8 
10.0 
24.7 
11.9 
47.4 
59.7 
24.1 
16.4 
2.5 
4.9 
9.6 
6.9 
6.1 
7.2 
12.0 
7.1 
18.8 
15.6 
11.9 
7.8 
Frail 
0.6 
2.2 
3.5 
5.6 
2.4 
4.0 
4.4 
5.6 
3.2 
3.6 
4.6 
5.1 
2.8 
5.3 
4.4 
5.8 
3.8 
5.8 
4.6 
5.7 
4.7 
6.2 
4.6 
5.8 
NOTES: FFS is fee-for-service. S/HMO is social/health maintenance organization. 
SOURCES: Data derived from health screening forms (HSFs) and comprehensive assessment forms (CAFs) administered by the authors. HSF data were collected from FFS 
beneficiaries at baseline and from S/HMO enrollees upon application. Total HSF sample size is 27,503 cases. CAFs were completed semiannually by persons who identified functional 
limitations on the HSF. 
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Table 7 
Health and Mortality Variables for Females at 75 and 85 Years of Age, by Case-Mix Group at 65 Years of Age 
Age at 
Evaluation 
75 Years 
85 Years 
Case-Mix 
Group at 65 
Years of Age 
Healthy 
Acutely III 
Impaired 
Pulmonary 
Cardiac 
Frail 
Healthy 
Acutely III 
Impaired 
Pulmonary 
Cardiac 
Frail 
Health 
Coverage 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
FFS 
S/HMO 
Life 
Expectancy 
15.7 
12.1 
12.1 
10.1 
12.5 
10.0 
11.5 
10.2 
11.4 
10.1 
12.5 
10.6 
9.3 
6.5 
8.3 
6.3 
8.4 
6.3 
8.2 
6.3 
8.2 
6.2 
8.4 
6.4 
Proportion 
Surviving -
in Percent 
85.4 
81.7 
52.5 
50.1 
59.8 
49.0 
48.7 
45.7 
48.1 
61.1 
52.8 
26.6 
62.9 
49.2 
28.6 
23.4 
34.0 
22.3 
24.8 
21.6 
24.1 
27.9 
29.9 
13.3 
Healthy 
94.1 
84.5 
38.6 
36.3 
43.7 
31.9 
31.1 
36.6 
29.6 
20.7 
43.8 
47.6 
73.4 
57.6 
46.5 
47.5 
48.9 
46.6 
42.9 
47.1 
42.6 
41.8 
48.9 
49.8 
Case-IV 
Acutely III 
0.7 
1.6 
8.4 
15.8 
7.5 
7.6 
6.7 
6.7 
6.5 
4.1 
8.7 
6.6 
1.6 
3.0 
3.5 
3.9 
3.3 
3.8 
3.6 
3.7 
3.6 
3.9 
3.4 
3.6 
lix Group 
Impaired 
0.8 
1.4 
10.1 
6.1 
17.0 
20.5 
8.6 
6.2 
8.3 
4.9 
10.4 
5.9 
4.7 
4.5 
13.6 
6.2 
14.3 
7.1 
14.0 
6.3 
14.1 
6.9 
13.1 
5.9 
at Evaluation 
Pulmonary 
2.3 
6.3 
16.1 
17.8 
12.5 
15.4 
14.6 
18.7 
14.4 
13.6 
16.2 
15.5 
14.6 
19.4 
23.2 
22.4 
21.6 
22.2 
24.1 
22.2 
24.3 
23.1 
22.5 
21.6 
Age 
Cardiac 
1.1 
4.4 
18.7 
18.2 
12.2 
19.6 
31.8 
25.9 
34.2 
53.0 
12.7 
18.1 
2.6 
8.0 
8.1 
11.6 
7.0 
11.9 
10.1 
12.4 
10.5 
15.9 
7.1 
11.1 
Frail 
1.0 
1.8 
8.1 
5.9 
7.2 
5.0 
7.2 
6.1 
7.0 
3.6 
8.3 
6.2 
3.2 
7.5 
5.1 
8.4 
4.9 
8.3 
5.3 
8.3 
5.3 
8.4 
5.0 
8.1 
NOTES: FFS is fee-for-service. S/HMO is social/health maintenance organization. 
SOURCES: Data derived from health screening forms (HSFs) and comprehensive assessment forms (CAFs) administered by the authors. HSF data were collected from FFS 
beneficiaries at baseline and from S/HMO enrollees upon application. Total HSF sample size is 27,503 cases. CAFs were completed semiannually by persons who identified functional 
limitations on the HSF. 
proportion that those years represent of 
life expectancy at that age. Male life ex-
pectancy at 65 years of age is 15.2 years in 
FFS and 14.9 years in S/HMO. The propor-
tion of ALE (13.2 years; 88.8 percent) in 
S/HMOs is higher than in FFS (10.7 years; 
70.8 percent), despite a lower life expect-
ancy. Male life expectancy is higher in 
FFS to 95 years of age with absolute ALE 
differences becoming small by 75 years 
of age (i.e., 8.5 years in FFS; 8.0 years in 
S/HMO). 
For females, life expectancy at 65 years 
of age is 3 years higher in FFS (21.4 years) 
than in S/HMOs (18.4 years). The ALE pro-
portion is similar (87.2 percent versus 87.4 
percent) at 65 years of age, though the ab-
solute difference is 2.6 years because of 
higher FFS life expectancy. At 75 years of 
age, ALE is absolutely and proportion-
ately higher in FFS (e.g., 86.2 percent ver-
sus 77.6 percent). 
For both genders the proportion of life 
lived frail is modestly higher in FFS at 65 
years of age and 95 years of age. It is 
higher in S/HMOs at 75 years of age and 
85 years of age. Because the frail have a 
high risk of institutionalization, it may be 
that the frail's greater prevalence in FFS 
at 95 years of age reflects nursing home 
restrictions in certifiable S/HMOs. 
AGE-SPECIFIC PROPORTIONS IN CASE-
MIX STATES 
The life tables in Table 5 reflect the 
case-mix distribution at enrollment (i.e., 
initial conditions for the different equa-
tions), which is favorably biased for 
S/HMOs. To control for this, Tables 6 and 
7 present case-mix distributions for 10-
and 20-year survivors of cohorts starting 
in the Kth case-mix group at 65 years of 
age—specific to gender and coverage. 
These provide, for each group, estimates 
of the expected number of remaining 
years of life at a given age (e.g., 75 years of 
age and 85 years of age), the proportion 
surviving a period, and the likelihood of 
changing case mix. 
Healthy males 65 years of age have a 
life expectancy at 75 years of age of 12.5 
years (FFS) and 9.8 years (S/HMO), with 
73.9 percent (FFS) and 71.0 percent 
(S/HMO) surviving 10 years. Males who 
are frail at 65 years of age have a life ex-
pectancy at 75 years of age of 9.3 years 
(FFS) and 8.4 years (S/HMO), with 37.3 per-
cent and 57.9 percent becoming healthy 
after 10 years. By 85 years of age, 44.2 per-
cent of healthy FFS males are alive; 32 
percent in S/HMOs. Similar proportions 
of surviving males stay healthy (75.2 per-
cent versus 74.5 percent). Of the frail, only 
12.8 percent (FFS) and 5.6 percent 
(S/HMO) survive 20 years. Of frail survi-
vors, 49.5 percent in FFS and 69.1 percent 
in S/HMOs become healthy by 85 years of 
age. The higher proportions becoming 
healthy in S/HMOs may be because of at-
trition (i.e., a smaller proportion of the frail 
survive in S/HMOs). 
In Table 7, life expectancy is higher for 
FFS females at 75 years of age and 85 
years of age. FFS has more healthy fe-
males (62.9 percent) surviving to 85 years 
of age than S/HMOs (49.2 percent). Sur-
vival is greater in FFS in all groups except 
the cardiac. S/HMO females in the car-
diac group had better survival at both 75 
years of age and 85 years of age. The frail 
group shows the greatest differences-
more than one-half (52.8 percent) of frail 
FFS females survive 10 years (i.e., to 75 
years of age), compared with 26.6 percent 
of frail S/HMO females. S/HMOs, by re-
stricting nursing home certifiable cases, 
may attract acutely ill and frail persons. 
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Table 8 
Life Expectancy, by Age, Health Coverage, and Case-Mix Group, by Gender 
Gender, Age, and 
Health Coverage 
Males 
65 Years: 
FFS 
S/HMO 
75 Years: 
FFS 
S/HMO 
85 Years: 
FFS 
S/HMO 
95 Years: 
FFS 
S/HMO 
Females 
65 Years: 
FFS 
S/HMO 
75 Years: 
FFS 
S/HMO 
85 Years: 
FFS 
S/HMO 
95 Years: 
FFS 
S/HMO 
Healthy 
23.6 
23.7 
19.7 
18.8 
16.3 
14.6 
13.5 
11.2 
33.4 
37.1 
27.9 
31.7 
23.0 
27.0 
19.0 
23.2 
Acutely III 
10.3 
14.5 
8.2 
11.0 
6.5 
8.2 
5.2 
6.0 
17.7 
18.2 
13.9 
14.7 
10.8 
11.7 
8.3 
9.3 
Case-Mix 
Impaired 
12.3 
7.6 
9.9 
5.6 
7.9 
4.0 
6.3 
2.8 
14.8 
14.3 
11.5 
11.4 
8.8 
9.0 
6.7 
7.0 
Group1 
Pulmonary 
8.7 
8.1 
6.9 
5.9 
5.4 
4.3 
4.3 
3.0 
13.0 
14.6 
10.0 
11.6 
7.6 
9.2 
5.7 
7.2 
Cardiac 
8.0 
11.4 
6.3 
8.6 
5.0 
6.3 
3.9 
4.5 
10.9 
20.6 
8.4 
16.8 
6.3 
13.5 
4.7 
10.8 
Frail 
5.1 
2.4 
4.0 
1.7 
3.1 
1.1 
2.4 
0.8 
7.4 
3.7 
5.5 
2.8 
4.1 
2.1 
3.0 
1.6 
1Years of remaining life after age χ in each case-mix group. 
NOTES: FFS is fee-for-service. S/HMO is social/health maintenance organization. 
SOURCES: Data derived from health screening forms (HSFs) and comprehensive assessment forms (CAFs) administered by the authors. 
HSF data were collected from FFS beneficiaries at baseline and from S/HMO enrollees upon application. Total HSF sample size is 27,503 
cases. CAFs were completed semiannually by persons who identified functional limitations on the HSF. 
By 75 years of age, one-half the frail fe­
male survivors in both types of coverage 
return to the healthy group. 
In Table 8 we set auto-regressive coeffi-
cients to 1.0(βkk = 1) and diffusion = 0 
to remove the effects of health changes. 
Comparing Table 8 with Tables 6 and 7 
identifies the effects of health changes. 
Table 8, for example, shows that frail 
males have a life expectancy at 65 years 
of age of 5.1 years in FFS and 2.4 years in 
S/HMOs. Life expectancy at 65 years of 
age in Tables 6 and 7 is higher because 
persons can either die or change health 
status. In Table 8, FFS healthy, impaired, 
and frail males live longer past 75 years of 
age. S/HMO males live longer only in the 
acutely ill and cardiac groups. S/HMO fe­
males are advantaged in the cardiac, 
healthy, acutely ill, and impaired groups. 
A survival advantage exists for FFS fe­
males manifesting attributes of the frail. 
Because the prevalence of frailty in­
creases with age, this mortality advan­
tage increased in Table 7, where disability 
dynamics were operating. 
A comparison of Tables 5 through 8 iso­
lates gender differences between out-
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comes in the two types of coverage attrib­
utable to initial conditions, health change, 
and mortality. For example, while FFS 
males have modestly better survival but 
worse ALE than S/HMO males in Table 5 
because of better initial conditions in 
S/HMOs, this changes in Table 6, with ini­
tial condition differences eliminated, 
where the proportion active stays higher 
for FFS males. For FFS females, life ex­
pectancy at 65 years of age is greater (3 
years) because groups where mortality 
differences favor FFS females are those 
into which disability dynamics, identified 
in Table 7, move females with age. Table 8 
describes the pure effects of mortality 
free of disability dynamics—one compo­
nent of the cohort experience. 
Gender differences between FFS and 
S/HMO, because θs are non-zero and dif­
fer in size, may reflect differences in un­
observed factors (e.g., widowhood). With­
out estimating θ, this effect would be 
subsumed in Q, causing those coeffi­
cients to be biased. The Qt include these 
effects but are evaluated at specific ages. 
Females have higher institutional risks 
above 85 years of age. For the elderly, the 
prevalence of dementia above 85 years of 
age could be as high as 47 percent (Evans 
et al., 1992) with 10 percent severely de­
mented. Though having high disability, 
Alzheimer's cases can have near normal 
life spans with good care. The initial ex­
clusion of institutionalized persons at all 
ages, given a high prevalence of dementia 
in institutions, removes many elderly, de­
mented persons from S/HMO eligibility. 
However, one could expect moderately 
demented elderly to be disproportion­
ately FFS clients (i.e., impaired groups 
tend to re-enter FFS). 
OUTCOME DIFFERENCES BY SITE AND 
GENDER 
To ascertain whether outcome differ­
ences are related to site, or to whether a 
S/HMO was established in a pre-existing 
HMO or a LTC organization, we calcu­
lated life tables for total and site-specific 
populations. The results are presented in 
Table 9. 
There are differences in life expectancy 
at 65 years of age (1.01 years) and 85 years 
of age (0.89 year) that favor FFS. Likewise, 
the proportion of individuals active at 75 
years of age is higher in FFS (2.0 percent), 
with the difference increasing with age (at 
85 years of age it is 6.7 percent). 
Site-specific results show that FFS life 
expectancy is higher in all sites at 65 
years of age and 85 years of age. The dif­
ference at 85 years of age is slightly larger 
than at 65 years of age, suggesting that it 
increases with time. The proportion of ac­
tive individuals is higher in FFS at 75 
years of age (reflecting a population that 
was enrolled in FFS for 10 years; a com­
parison at 65 years of age reflects only ini­
tial conditions) and increases at 85 years 
of age. The differences are similar across 
sites and do not vary by whether the 
S/HMO was started by an HMO or a LTC 
provider. There is a slight advantage at 85 
years of age in the proportion of enrollees 
active in the two LTC organization-based 
S/HMOs (6.4 percent and 5.9 percent) over 
the differences relative to FFS in the two 
HMO-based S/HMOs (6.6 percent and 7.1 
percent). 
DISCUSSION AND CONCLUSION 
S/HMOs integrate medical, health, and 
social services which, with financial risk, 
are designed to improve services and 
control costs. The issue addressed here 
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Table 9 
Comparison of Life Expectancy and Active Life Expectancy, by Site and Type of Health Coverage, by Age and Gender 
Health Coverage 
and Site 
S/HMO 
FFS 
Δ 
Established in HMOs 
Minneapolis: 
S/HMO 
FFS 
Δ 
Portland: 
S/HMO 
FFS 
Δ 
Established in LTC 
Organizations 
Brooklyn: 
S/HMO 
FFS 
Δ 
Long Beach: 
S/HMO 
FFS 
Δ 
65 
16.85 
17.83 
1.01 
17.83 
18.35 
0.52 
16.71 
16.96 
0.25 
16.61 
17.14 
0.53 
16.49 
16.96 
0.47 
Male 
14.9 
15.2 
15.8 
16.3 
0.5 
14.2 
14.4 
0.2 
14.0 
14.4 
0.4 
13.8 
14.4 
0.6 
Life Expectancy at Age 
Female 
18.4 
21.4 
19.2 
21.7 
2.5 
18.4 
18.7 
0.3 
19.2 
19.9 
0.7 
18.1 
18.5 
0.4 
85 
6.09 
6.98 
0.89 
6.37 
7.36 
1.02 
5.86 
6.67 
0.81 
6.37 
7.39 
1.02 
6.24 
7.22 
0.98 
Male 
5.6 
7.1 
5.7 
7.7 
2.0 
5.6 
6.3 
0.7 
5.0 
5.9 
0.9 
5.2 
6.3 
1.1 
Female 
6.5 
9.2 
7.0 
10.1 
3.1 
6.5 
8.2 
1.7 
7.7 
8.9 
1.2 
6.7 
7.7 
1.0 
75 
79.7 
81.7 
2.0 
80.1 
82.1 
2.0 
79.2 
81.5 
2.3 
80.4 
82.3 
1.9 
80.9 
82.9 
2.0 
Male 
— 
— 
82.6 
84.3 
1.7 
80.5 
82.8 
2.3 
82.4 
84.3 
1.9 
83.7 
85.1 
1.4 
Proportion 
Female 
— 
— 
79.3 
81.4 
2.1 
78.6 
80.8 
2.2 
79.2 
81.1 
1.9 
79.6 
81.7 
2.1 
Active at Age 
85 
Percent 
62.3 
69.0 
6.7 
63.0 
69.6 
6.6 
61.4 
68.5 
7.1 
63.2 
69.6 
6.4 
64.1 
70.6 
5.9 
Male 
— 
— 
68.1 
73.7 
5.6 
64.8 
71.6 
7.2 
68.4 
74.1 
5.7 
70.5 
75.2 
4.9 
Female 
— 
— 
60.9 
67.7 
6.8 
59.7 
66.8 
7.1 
60.0 
66.6 
6.6 
61.3 
68.4 
7.1 
NOTES: S/HMO is social/health maintenance organization. FFS is fee-for-service. LTC is long-term care. Delta represents difference between S/HMO and FFS. 
SOURCES: Data derived from health screening forms (HSFs) and comprehensive assessment forms (CAFs) administered by the authors. HSF data were collected from FFS 
beneficiaries at baseline and from S/HMO enrollees upon application. Total HSF sample size is 27,503 cases. CAFs were completed semiannually by persons who identified functional 
limitations on the HSF. 
is whether S/HMOs improved for mem-
bers, over that for comparable FFS cli-
ents, age and gender-specific functional 
status, and mortality. To describe func-
tional status, 30 items from the HSF and 
CAF were used to define 6 case-mix 
groups ranging from healthy to frail using 
a multivariate procedure. Groups were up-
dated when a health change was mea-
sured in a CAF. 
The case-mix groups are used to con-
trol health variation in two analyses. The 
first describes time to events within the 3-
year study period. The second uses pa-
rameters estimated from the study to cal-
culate cohort life tables, specific to 
gender and coverage. In cohort life tables, 
disability dynamics and mortality interact, 
though, by adjusting the coefficients in 
the difference equations, specific fea-
tures of the health and mortality pro-
cesses can be isolated. In the analysis of 
the 36 months of followup, lifetime impli-
cations of the differences between 
S/HMO and FFS experiences cannot be 
estimated. Differences in health changes 
past 36 months are not observed, so even 
censoring and "length biased" sampling 
will affect standard statistical analyses. 
The difference equations for the life table 
calculations allow the partial (i.e., 36 
month) experience of persons at different 
ages to be composed to extrapolate the 
lifetime experience of specific cohorts 
using a multidimensional stochastic pro-
cess model. Such calculations, though re-
quiring assumptions about the form of 
the difference equations, allow estimates 
to be made for lifetime behavior—esti-
mates impossible to make directly with-
out bias with only 36 months of observa-
t ion. Also, the difference equations 
reflect the dynamic interaction of health 
changes and mortality—this cannot be 
estimated as coefficients in a regression 
function. Thus, it is necessary to manipu-
late the difference equations, as done in 
Tables 5 through 8, to isolate the effects 
of initial conditions, health dynamics, and 
mortality selection for subgroups in the 
study. The problems of limited followup 
and the interaction of health changes and 
mortality, are found in many longitudinal 
observational and demonstration studies. 
In Table 5, total life expectancy differed 
little for males, even though S/HMO males 
had an early ALE advantage reflecting an 
initially favorable case mix. For FFS fe-
males, in contrast, there is a life expect-
ancy of 3 more years at 65 years of age; 
2.6 years more of ALE. FFS life expect-
ancy is high, relative to U.S. cross-section-
al life tables (National Center for Health 
Statistics, 1989). However, institutional-
ized persons at all ages are initially "out 
of scope" for the FFS sample and 
S/HMOs. Thus, the life expectancy esti-
mate should reflect the survival of per-
sons of all ages initially non-institution-
alized. This would have greater effects on 
females, persons of advanced age, and 
persons with dementia—all groups with 
high institutionalization rates. An effect 
of the anticipated direction and size is 
found in FFS but not in S/HMOs (Branch 
et al., 1991; Lew and Garfinkel, 1984, 
1987). 
Initial differences in case mix are ad-
justed in Tables 6 through 8 by analyzing 
survival and disability changes within 
case-mix groups. Non-response affects 
the proportion of cases initially in a group, 
but not its dynamics. Adjusting for the ini-
tial case mix (as in Tables 6 and 7) im-
proves the relative performance of FFS 
clients in terms of the proportion active at 
specific ages. Healthy FFS clients are 
more likely to stay so at 75 years of age 
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and 85 years of age. S/HMO males and fe-
males are likely to become relatively more 
healthy—but because of higher attrition 
rates in impaired groups. FFS survival is 
better for the impaired. Thus, while more 
surviving S/HMO male members are 
healthy, survival is worse for impaired 
groups, or for those with both acute ill-
ness and impairment (i.e., persons jointly 
in acutely ill, impaired, or frail groups). For 
females a mortality advantage occurs for 
the impaired and frail groups. 
In considering outcome differences, 
several factors are relevant. First, it is dif-
ficult to demonstrate effects in commu-
nity trials because innovation may affect 
controls (Brown and Mossell, 1984). If in-
novation is rapid, FFS clients may have 
access to new forms of care, while 
S/HMO members are restricted to a fixed 
set of services. The National Long-Term 
Care Channeling demonstration showed 
that controls often obtained LTC on their 
own (Manton, Vertrees, and Clark, 1993). 
Thus, what is usual and customary FFS 
care may change over the study, e.g., 
growth in the use of post-acute and home 
health services in the 1980s by Medicare-
eligible persons (Manton et al., 1993). The 
out-of-pocket purchase of equipment and 
supplemental LTC services is further fa-
cilitated as the average income and edu-
cation of new elderly cohorts increase. 
Therefore, S/HMO services (and their defi-
nition of and approach to "high risk" 
chronic care cases) have to be as adaptive 
as the private LTC market available for 
controls—especially for females—a gen-
eral problem in the U.S. health care sys-
tem (Ayanian and Epstein, 1991; Khan et 
al., 1990; Maynard et al., 1992; Steingart et 
al.,1991). 
Second, S/HMOs are intended to allo-
cate resources efficiently. Plans operate 
within benefit guidelines and LTC screen-
ing criteria, but vary in emphasis on reha-
bilitation or prevention. S/HMO interven-
tions were not fixed over time, in contrast 
to standard clinical trials (e.g., geriatric 
evaluation units, where procedures for im-
proving function and survival in the frail el-
derly were tested in randomized designs 
with fixed case and control groups [Ru-
benstein and Josephson, 1989]). A num-
ber of interventions have been shown in 
such trials to improve the health and func-
tioning of the elderly, e.g., physical activ-
ity (Fiatarone et al., 1990), nutritional sup-
plementation (Bastow, 1983a, 1983b; 
Gerster, 1991; Larsson et al., 1990; Penn et 
al., 1991a, 1991b; Tilyard et al., 1992), im-
proved medical and surgical treatments 
(Gold et al., 1991; Hosking et al., 1989; 
SHEP Cooperative Research Group, 
1991). S/HMO health outcomes might 
have improved had they adopted recently 
proven geriatric evaluation and treatment 
innovations. 
This analysis, in addition to illustrating 
a general methodology for analyzing lon-
gitudinal studies of capitated plans, 
where randomization into case and con-
trol groups is inconsistent with study 
goals, identifies several features of 
S/HMO performance relative to FFS care 
with health policy implications. 
First, it is clear, because of the large ini-
tial case-mix differences between the FFS 
population and those electing to enter 
S/HMOs, that capitation-based systems 
providing extended and LTC services can 
be more effective if rates are adjusted for 
detailed case-mix measures—and not 
just for the four average annual per capita 
cost factors (i.e., age, gender, Medicaid, 
and institutional status) that are known 
not to predict individual service costs. If 
this were done, then the problems of per-
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sons with high institutional risks and LTC 
needs (e.g., those with dementia, the 
oldest-old, females with specific health 
problems) could be directly addressed in 
capitated organization. 
Second, little difference in outcome is 
found between S/HMOs started in estab­
lished HMOs versus those started by LTC 
providers. In both cases acute care 
seems to be adequate. Neither appears to 
perform especially well in providing 
LTC—though S/HMOs started by LTC 
providers may do marginally better. This 
may be because of the restrictions placed 
on LTC eligibility and benefits which limit 
the provision of necessary LTC services. 
Third, S/HMOs seem to perform HMO 
functions well, as indicated by the relative 
health success of the healthy and acutely 
ill. This is confirmed by the similarity of 
outcomes for specific case-mix groups 
between S/HMO enrollees and those FFS 
members entering HMOs during the 
study. However, S/HMOs perform less 
well for impaired persons, or for acutely ill 
persons with chronic impairments. Thus, 
LTC services provided by the S/HMOs, 
and their integration with acute care, do 
not seem effective. 
This is illustrated by major gender dif­
ference in outcomes. Males, who have a 
lower disability prevalence, and are im­
paired for shorter periods of time, have 
similar life expectancy outcomes as seen 
in Table 5. FFS females have large advan­
tages. Because females have higher dis­
ability prevalence, are disabled for longer 
periods of time, and, because of widow­
hood, are at greater risk of institutionaliza­
tion, this suggests that LTC services pro­
vided in S/HMOs were not effective in 
improving their functional status—espe­
cially among elderly females who have 
the greatest LTC needs. 
Gender differences are explored in a se­
ries of analyses in Tables 5 through 8. In 
Table 5, large differences in total life ex­
pectancy and ALE for FFS females were 
found even with favorable S/HMO enroll­
ment. In Table 7, we removed the effects 
of favorable enrollment and still found ad­
vantages for FFS females. In Table 6, with 
the favorable enrollment for S/HMO 
males eliminated, FFS males had better 
outcomes. In Table 8 all disability dynam­
ics (i.e., case-mix changes) are eliminated 
to generate life expectancy estimates for 
persons who remain in specific case-mix 
groups from 65 years of age. In this case, 
FFS males do well in all but the acutely ill 
and cardiac group, while only the frail do 
better for FFS females. Thus, the advan­
tages observed in Tables 5 and 7 for FFS 
females are because of disability transi­
tions over time and age. When disability 
dynamics are eliminated, the mortality 
patterns for each case-mix group are less 
favorable for FFS females (except for the 
frail). Thus, much of the disadvantage for 
S/HMO females may be because of a fail­
ure to keep persons from moving into im­
paired categories where FFS females are 
advantaged. For males, in contrast, be­
cause the age dependence of mortality 
(i.e., θ is smaller) is favorable for FFS, 
there are still improvements with age in 
Table 8. 
Thus, the different tables isolate the ef­
fects of initial conditions (i.e., case mix at 
enrollment), disability changes, and mor­
tality. FFS females have advantages in 
terms of disability changes. FFS males 
have mortality advantages at latter ages. 
S/HMOs start with an advantaged initial 
case mix. Thus, there is a need to re­
evaluate the LTC provided by S/HMOs to 
determine how to better serve the chroni­
cally disabled elderly female population 
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and to slow their rate of disability onset. 
This is now more feasible than when the 
S/HMO demonstrations started, because 
a number of innovative therapies and pro-
cedures have recently been demon-
strated to be effective in improving func-
t ion and survival (physical therapy 
[Rubenstein and Josephson, 1989]; nutri-
tional supplementation [Fiatarone et al., 
1990]). Furthermore, results from national 
surveys (Manton, border, and Stallard, 
1993) show that rates of disability onset 
have declined nationally from 1984 to 
1990. Even without intervention, the gen-
eral U.S. elderly population shows de-
clines in disability. Presumably S/HMO 
enrollees should do better than the gen-
eral population without specialized inte-
grated care. The method of reimbursing 
capitated systems to provide necessary 
LTC services to impaired elderly must be 
redesigned before capitated plans can 
deal effectively with this portion of the 
health service needs of the U.S. elderly 
population. 
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